Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04607616
Other study ID # APHP180671
Secondary ID 2019-A02707-50
Status Recruiting
Phase N/A
First received
Last updated
Start date March 26, 2021
Est. completion date January 2026

Study information

Verified date December 2023
Source Assistance Publique - Hôpitaux de Paris
Contact Lisa OUSS, MD
Phone +33 1 44 49 45 61
Email lisa.ouss@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the effect of Interactive Guidance Therapy with video feed back (IGT) of parent and child with Autism Spectrum Disorder, under three years of age, using a Single Case Experimental Design (SCED) with multiple baseline across subjects, multicentric, randomized, with multiple replications, blinded scored


Description:

The purpose of this study is to assess the effect of Interactive Guidance Therapy with video feed back (IGT) of parent and child with Autism Spectrum Disorder, under three years of age, using a Single Case Experimental Design. Early Interventions in Autism Spectrum Disorders (ASD) undergo a major development. The investigators identify three generations of early support: 1) Behavioral studies ; 2) Early Intensive Behavioral Interventions (EIBI), inspired by ABA, focused on targeted ASD disorders 3) Naturalistic Behavioral Developmental Behavioral Interventions (NDBI), more ecological, focused on the child's skills. Among them, methods of video feedback target parental sensitivity (identification, interpretation, response, contingency and synchrony). The VIPP (Video Interactive Positive Parenting) in children less than one year of age, has shown moderate and long term effects on parent-child interaction. The PACT (Preschool Autism Communication Trial) showed immediate and in the long term effects on the synchronization of the parental response, the child initiation, less importantly on the joint attention, and on the autistic symptoms. The dyadic communication allows for changes in autistic symptoms. Interactive guidance is a brief video-feedback therapy, based on the analysis of "the here and now" with the parent (s), of videotaped interactions with their child. The objective is to strengthen parental skills, their sensitivity, their ability to decipher and respond to the specific needs of their child. The interest of IGT in the field of ASD, compared to VIPP and PACT, is to offer a standardized feedback intervention adapted to each dyad, according to the child's and parents skills and difficulties, structured on the "here and now" more than on a predetermined sequence of goals. The investigators use the Single Case Experimental Design (SCED) with multiple baseline across subjects, multicentric, randomized, with multiple replications, blinded scored. They expect - to improve the interactive and communicative basic skills of the child, soon after the ASD diagnosis, by accompanying the parents in the identification and understanding of their child's disorders. - to propose a method highlighting parental skills, in a collaborative and pleasant way - To increase the parental alliance in the implementation of a tailored intervention for the child - To facilitate access to healthcare and reduce the parental wandering in the implementation of intervention


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date January 2026
Est. primary completion date October 2025
Accepts healthy volunteers No
Gender All
Age group 18 Months to 3 Years
Eligibility Inclusion Criteria: - 18 months to 3 years child at screening - Child with a diagnosis of Autism Spectrum Disorder (DSM 5) or pervasive Developmental Disorder (ICD 10) - Child with ADI R and ADOS-2 fulfilling the criteria for TSA / PDD at diagnosis - Developmental age > 12 months in motility with the Brunet-Lézine test - Child with availability of parent most present in daily life, only this parent participating directly in play sessions - Signed Informed consent form by both parents - Patient affiliated to the health insurance system Exclusion Criteria: - Level of language in French of parents insufficient to benefit from the care and fill in the questionnaires - Psychiatric parental pathology interfering with interactions with the child, qualitatively assessed by the referring psychiatrist - Severe sensory illness of the child (blindness, deafness, degenerative disease)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Baseline sessions TAU
TAU consists of sessions lasting around one/one and a half hour ; the consultant is practicing as usual. The interventions focus on child's behavior, parent infant relationship, with moments of play with the child, advices, informations about child development and Autism.
Interactive guidance therapy
The objective is to reinforce the identification, deciphering, interpretation, and answer to child's signals by the parent, in order to to promote a synchronous and attuned response to the child's needs. Sessions last around one/one and a half hour. Parent plays 7-10 minutes with the child, in the presence of the therapist, with toys chosen according to the child's developmental stage. Then therapist proposes an immediate viewing of the play session. The therapist selects short moments of positive interaction. He has determined a " focus ", depending on the play, previous sessions, the child's difficulties and parent's interventions. He accompanies, guides and supports the parent to describe the interaction, the alternance in play, joint attention, shared affect, in a co-construction: the parent discovers the child's and his own skills.
Diagnostic Test:
Developmental and diagnostic assessments
MSEL, CARS, ECAR, CIM10, DMS5, ADOS, ADIR
Behavioral:
Developmental assessment -Parental scales
Vineland II, IFDC, IDE
Qualitative analysis
Interpretative Phenomenological Analysis. Parents' semi structured interview about the Interactive Guidance experience. Qualitative analysis of transcripts (recurrent themes, meta themes).

Locations

Country Name City State
France Hôpital Saint Eloi Montpellier
France Hôpital Ville Evrard Montreuil
France Hôpital Necker Enfants Malades Paris
France Hôpital Pitié Salpétriere Paris

Sponsors (2)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Ville Evrard Hospital

Country where clinical trial is conducted

France, 

References & Publications (3)

1. McDonough S. Interaction guidance. Treat Parent-infant Relatsh Probl Strateg Interv. 2004;79-96.

2. McDonough SC. Promoting positive early parent-infant relationships through interaction guidance. Child Adolesc Psychiatr Clin N Am. 1995;4(3):661-72.

Rusconi-Serpa S, Sancho Rossignol A, McDonough SC. Video feedback in parent-infant treatments. Child Adolesc Psychiatr Clin N Am. 2009 Jul;18(3):735-51. doi: 10.1016/j.chc.2009.02.009. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of time spent in a joint attention situation Coordinated Joint Attention (COJ) rate is evaluated during the parents-child play-time Up to 15 months
Primary Percentage of time spent in a joint attention situation Supported Joint Attention (SUJ) rate is evaluated during the parents-child play-time Up to 15 months
Secondary Parent-child interactive features/ joint attention - SUJ and COJ rate initiated by child Up to 15 months
Secondary Parent-child interactive features / DCMA scale - DCMA: dyadic communication measure in autism Up to 15 months
Secondary Parent-child interactive features / Parental synchrony - number of parental responses in synchrony with child Up to 15 months
Secondary Parent-child interactive features / Communication - Number conversational turns of speech between the child and the parent Up to 15 months
Secondary Parent-child interactive features / Initiation of communication - Initiation of communication by the child with the parent : in proportion to the child's acts of communication Up to 15 months
Secondary Child development / MSEL - MSEL : is Mullen Scale of Early Learning evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Child development / CDI - CDI is Child Development Inventory evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Child development / IFDC - IFDC is French adaptation of MacArthur-Bates Communicative Development Inventories evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Autistic Symptoms / CARS CARS is Childhood Autism Rating Scale evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Autistic Symptoms ECAR ECA R is "Evaluation des comportements autistiques Révisée" Scale evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Autistic Symptoms ADOS-2 ADOS-2 is Autism diagnostic observation Schedule evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Autistic Symptoms ADIR ADI R is Autism Diagnosis Interview Revised evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Adaptive behavior of the child Vineland 2 Scale evaluated at inclusion visit, guidance session 1, guidance session 10 and guidance session 15 Up to 15 months
Secondary Change process Psychotherapy Process Q-set evaluated at baseline visit 1 and last baseline visit (depend of randomization), guidance session 1 and guidance session 10 Up to 15 months
Secondary Content analysis of guidance session by parent Targeted interview of parents with the psychologist on the content of guidance session At 16 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02625116 - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting NCT06381856 - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting NCT02280746 - Gluten for Autism Spectrum Disorders N/A
Completed NCT01945957 - Brain Imaging of Intranasal Oxytocin Treatment in Autism Phase 1
Completed NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Phase 2
Completed NCT01780090 - Handheld Technology for Speech Development in Students With Autism N/A
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder N/A
Completed NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder Phase 2
Active, not recruiting NCT01417026 - Intranasal Oxytocin and Learning in Autism Phase 2
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Completed NCT01695200 - Omega-3 Fatty Acids in Autism Spectrum Disorders Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Not yet recruiting NCT00695812 - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age N/A
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT02081027 - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Early Phase 1
Completed NCT02797379 - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT01603225 - Transcranial Direct Current Stimulation and Autism